Wilson Wolf Manufacturing Corporation provides contract engineering and manufacturing resources for medical device suppliers. The company develops products that advance the field of cell culture by creating devices that bridge the gap between traditional cultureware (t-flasks and roller bottles) and sophisticated devices like WAVE bioreactors and hollow fiber bioreactors. The firms efforts have led to highly beneficial devices that typically rely on the use of gas permeable material and/or dialysis membranes to provide a healthier environment for cells that utilizes less labor, less material, less space, and makes downstream processing much easier. The firm is currently developing its G-Rex technology platform for cell production in Adoptive Immunotherapy. Applications proven to be much more efficient in G-Rex Devices include: T Cell culture (research and clinical production of antigen-specific T cells, CAR T cells, EBV-CLT, TIL, NK, Treg, HSC, LCL, K562, etc.) Monoclonal and recombinant antibody production (hybridoma, CHO, 293, etc.) Islet culture (up to 4000 IE/cm2).